Outcomes and prognostic factors of decompensated pulmonary hypertension in the intensive care unit

Imagem de Miniatura
Arquivos
art_GARCIA_Outcomes_and_prognostic_factors_of_decompensated_pulmonary_hypertension_2021.PDF (1.97 MB)
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
W B SAUNDERS CO LTD
Autores
Citação
RESPIRATORY MEDICINE, v.190, article ID 106685, 7p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Patients with acute decompensation of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) admitted to intensive care unit (ICU) have high in-hospital mortality. We hypothesized that pulmonary hypertension (PH) severity, measured by a simplified version of European Society of Cardiology/European Respiratory Society (ESC/ERS) risk assessment, and the severity of organ dysfunction upon ICU admission, measured by sequential organ failure assessment score (SOFA) were associated with in-hospital mortality in decompensated patients with PAH and CTEPH. We also described clinical and laboratory variables during ICU stay. Methods: Observational study including adults with decompensated PAH or CTEPH with unplanned ICU admission between 2014 and 2019. Multivariate logistic regression models were used to evaluate the association of ESC/ERS risk assessment and SOFA score with in-hospital mortality. ESC/ERS risk assessment and SOFA score were included in a decision tree to predict in-hospital mortality. Results: 73 patients were included. In-hospital mortality was 41.1%. ESC/ERS high-risk group (adjusted odds ratio = 95.52) and SOFA score (adjusted odds ratio = 1.80) were associated with in-hospital mortality. The decision tree identified four groups with in-hospital mortality between 8.1% and 100%. Nonsurvivors had a lower central venous oxygen saturation, higher arterial lactate and higher brain natriuretic peptide in the end of first week in the ICU. Conclusions: High-risk on a simplified version of ERS/ESC risk assessment and SOFA score upon ICU admission are associate with in-hospital mortality. A decision tree based on ESC/ERS risk assessment and SOFA score identifies four groups with in-hospital mortality between 8.1% and 100%.
Palavras-chave
Intensive care unit, Pulmonary hypertension, Pulmonary arterial hypertension, Chronic thromboembolic pulmonary, hypertension, SOFA score, ECS/ERS risk assessment
URI
https://observatorio.fm.usp.br/handle/OPI/44376
Referências
  1. Auger WR, 2007, CLIN CHEST MED, V28, P255, DOI 10.1016/j.ccm.2006.11.009
  2. Bauer SR, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0524-y
  3. Bigs D., 1991, J APPL STAT, V18, P49, DOI 10.1080/02664769100000005
  4. Boucly A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00889-2017
  5. Campo A, 2011, EUR RESPIR J, V38, P359, DOI 10.1183/09031936.00148310
  6. CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
  7. Costa RT, 2018, J CRIT CARE, V45, P52, DOI 10.1016/j.jcrc.2017.12.024
  8. Elias A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77967-2
  9. ffrench-O'Carroll R, 2015, Ir Med J, V108, P114
  10. Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
  11. Hoeper MM, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00740-2017
  12. Hoeper MM, 2011, AM J RESP CRIT CARE, V184, P1114, DOI 10.1164/rccm.201104-0662CI
  13. Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC
  14. Huynh TN, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.08.006
  15. Kurzyna M, 2008, KARDIOL POL, V66, P1033
  16. Lecuyer L, 2007, CRIT CARE MED, V35, P808, DOI 10.1097/01.CCM.0000256846.27192.7A
  17. Lederer DJ, 2019, ANN AM THORAC SOC, V16, P22, DOI 10.1513/AnnalsATS.201808-564PS
  18. Maphula RW, 2020, HIV MED, V21, P334, DOI 10.1111/hiv.12834
  19. Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931
  20. Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5
  21. Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3
  22. Peugh JL, 2010, J SCHOOL PSYCHOL, V48, P85, DOI 10.1016/j.jsp.2009.09.002
  23. Savale L, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0092-2017
  24. Saydain G, 2015, CLIN MED INSIGHTS-CI, V9, P27, DOI 10.4137/CCRPM.S22199
  25. Shrime MG, 2016, JAMA ONCOL, V2, P76, DOI 10.1001/jamaoncol.2015.3336
  26. Sztrymf B, 2010, EUR RESPIR J, V35, P1286, DOI 10.1183/09031936.00070209
  27. Textor J, 2016, INT J EPIDEMIOL, V45, P1887, DOI 10.1093/ije/dyw341
  28. Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1016/S0140-6736(07)61602-X, 10.1157/13119325]
  29. Vieillard-Baron A, 2018, INTENS CARE MED, V44, P774, DOI 10.1007/s00134-018-5172-2
  30. Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156
  31. Yataco AC, 2016, HEART FAIL REV, V21, P323, DOI 10.1007/s10741-015-9514-7
  32. YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/09
Artigos e Materiais de Revistas Científicas - ODS/03